Pharmacokinetics using fluorine NMR in vivo
- 1 July 1998
- journal article
- review article
- Published by Elsevier in Progress in Nuclear Magnetic Resonance Spectroscopy
- Vol. 33 (1), 1-56
- https://doi.org/10.1016/s0079-6565(98)00016-8
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- In vivo19F NMR studies of hyperthermia: Hydrophobic environments probed by halothaneNMR in Biomedicine, 1993
- Positron emission tomography for tumour assessmentNMR in Biomedicine, 1992
- Pharmacokinetics of 5-Fluorouracil After Short Systemic InfusionTherapeutic Drug Monitoring, 1991
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- 19F NMR imaging of blood oxygenation in the brainMagnetic Resonance in Medicine, 1988
- In vivo determination of body iron stores by natural-abundance deuterium magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1987
- Depth pulse sequences for surface coils: spatial localization and T1 measurementsMagnetic Resonance in Medicine, 1984
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Fluorine-19 nuclear magnetic resonance investigation of the ternary complex formed between native thymidylate synthetase, 5-fluoro-2'-deoxyuridylate, and 5,10-methylenetetrahydrofolateJournal of the American Chemical Society, 1977
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957